ATE306274T1 - Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis - Google Patents

Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis

Info

Publication number
ATE306274T1
ATE306274T1 AT98955313T AT98955313T ATE306274T1 AT E306274 T1 ATE306274 T1 AT E306274T1 AT 98955313 T AT98955313 T AT 98955313T AT 98955313 T AT98955313 T AT 98955313T AT E306274 T1 ATE306274 T1 AT E306274T1
Authority
AT
Austria
Prior art keywords
gram
vagina
acidity
positive bacilli
glycogen
Prior art date
Application number
AT98955313T
Other languages
English (en)
Inventor
Zhongming Zeng
City Shenzhen
Original Assignee
Zhongming Zeng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongming Zeng filed Critical Zhongming Zeng
Application granted granted Critical
Publication of ATE306274T1 publication Critical patent/ATE306274T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98955313T 1997-11-24 1998-11-24 Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis ATE306274T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN97122790 1997-11-24
PCT/CN1998/000278 WO1999026636A1 (fr) 1997-11-24 1998-11-24 Formulation pharmaceutique de stimulation de la croissance de bacilles gram positifs et d'augmentation de l'acidite du vagin et leur utilisation

Publications (1)

Publication Number Publication Date
ATE306274T1 true ATE306274T1 (de) 2005-10-15

Family

ID=5176887

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98955313T ATE306274T1 (de) 1997-11-24 1998-11-24 Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis
AT98955312T ATE304362T1 (de) 1997-11-24 1998-11-24 Pharmazeutische zusammensetzung zur stimulierung des wachstums von gram-positiven bazillen und zur erhöhung der azidität der vagina und ihre verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98955312T ATE304362T1 (de) 1997-11-24 1998-11-24 Pharmazeutische zusammensetzung zur stimulierung des wachstums von gram-positiven bazillen und zur erhöhung der azidität der vagina und ihre verwendung

Country Status (7)

Country Link
US (2) US6632796B1 (de)
EP (2) EP1072268B1 (de)
CN (2) CN1120000C (de)
AT (2) ATE306274T1 (de)
AU (2) AU1223099A (de)
DE (2) DE69831878D1 (de)
WO (2) WO1999026636A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306141B1 (it) * 1999-05-17 2001-05-30 Giampiero Valletta Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
US6964949B2 (en) * 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
JP2002113041A (ja) 2000-10-11 2002-04-16 Uni Charm Corp 皮膚常在菌をコントロールする吸収性物品
US20030017207A1 (en) * 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
NZ515869A (en) 2001-11-30 2003-09-26 Med Chem Ingredients Ltd Compositions and methods for animal treatment comprising gluco- and isomalto- oligosaccharides
US6589216B1 (en) 2002-02-20 2003-07-08 Abbott Research Group, Inc. Vaginal douches, vaginal douche applicators and methods of vaginal douching
US7270653B2 (en) 2002-02-20 2007-09-18 Abbott Research Group Methods of treating abnormal biological conditions using metal oxides
US8118789B2 (en) 2002-02-20 2012-02-21 Abbott Research Group, Inc. Deodorizer devices and systems for controlling perspiration-related body odor
US20040126369A1 (en) * 2002-12-30 2004-07-01 Richard Payne Delivery of peroxide-generating enzymes to the vaginal tract
US9241997B2 (en) * 2003-06-13 2016-01-26 Idh Holding Aps Treatment of symptoms associated with bacterial vaginosis
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
US7276486B2 (en) * 2004-03-15 2007-10-02 Kimberly-Clark Worldwide, Inc. Compositions for vaginal treatment
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060217443A1 (en) * 2005-03-28 2006-09-28 Kimberly-Clark Worldwide, Inc. Method for preventing and/or treating vaginal and vulval infections
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
EP1911454B1 (de) * 2005-04-27 2012-01-11 Shenzhen Phlora Biotechnology Limited Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
US7801502B2 (en) * 2006-12-18 2010-09-21 Aai Corporation Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems
AU2010206221B2 (en) 2009-01-23 2016-07-14 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Controlled release pharmaceutical or food formulation and process for its preparation
KR101133723B1 (ko) * 2009-10-19 2012-04-09 최원석 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
US8409628B2 (en) 2010-02-04 2013-04-02 Penguin IP Holdings, Inc. Methods and compositions for oxygenation of skin to treat skin disorders
EP2489408A1 (de) 2011-01-13 2012-08-22 Michael Tchirikov Aminosäurezusammensetzung und deren Verwendung zur Behandlung von fetaler Wachstumsrestriktion (IUGR) und zur parenteralen Ernährung von extrem Frühgeborenen
CN103110973A (zh) * 2013-01-24 2013-05-22 量子高科(中国)生物股份有限公司 保护生殖道微生态健康平衡的方法
CN107073019B (zh) * 2014-03-13 2020-04-17 深圳优丽康生物技术有限公司 一种阴道用组合物与该组合物的用途
CN104825946A (zh) * 2015-04-10 2015-08-12 付秀花 一种洁阴洗液及其制备方法
PL3324938T3 (pl) * 2015-07-20 2022-01-10 Trilogic Pharma Llc Preparaty do stosowania miejscowego i sposoby leczenia
CN108235682A (zh) 2015-09-29 2018-06-29 金伯利-克拉克环球有限公司 用于维护微生物群落的健康平衡的协同组合物
US9913871B2 (en) 2016-04-15 2018-03-13 Fairhaven Health, Llc Compositions and methods for maintaining or enhancing homeostasis or function of female lower reproductive tract
WO2018160158A1 (en) 2017-02-28 2018-09-07 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
CN109771434A (zh) * 2019-03-07 2019-05-21 江西鼎中科技有限公司 一种治疗阴道炎的蔗糖和低聚木糖凝胶
GB202018068D0 (en) 2020-11-17 2020-12-30 Ucl Business Ltd Pharmaceutical composition
CN112451472A (zh) * 2020-11-27 2021-03-09 江苏威克斯医疗科技有限公司 一种调节阴道微生态的组合物及其制备方法
EP4324465A1 (de) * 2022-08-15 2024-02-21 Gedea Biotech AB Verbindungen zur verwendung bei der behandlung einer mikrobiellen infektion im urogenitalsystem

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390803A (en) * 1972-07-18 1975-04-16 Wootton L W Medicinal tampons and compositions containing lactulose
IT1172185B (it) * 1981-12-21 1987-06-18 Serono Ist Farm Composizione particolarmente per la vande vaginali
DE3686893T2 (de) * 1985-02-08 1993-02-11 Daicel Chem Gaerung zur gewinnung von d-milchsaeure.
JPS61227777A (ja) * 1985-04-02 1986-10-09 Showa Sangyo Kk ビフイズス菌生育活性剤
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
US4837154A (en) * 1987-01-14 1989-06-06 Wisconsin Alumni Research Foundation Selective growth medium for isolation of Mobiluncus from vaginal fluid
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5211971A (en) * 1989-10-23 1993-05-18 Unilever Patent Holdings B.V. Lactic acid bacteria cultures supported on an expanded cereal for preparing flavor or aroma material
ATE214592T1 (de) * 1990-12-21 2002-04-15 Felice Bombart Wässrige vaginaldusche und deren anwendung
US5573765A (en) * 1991-02-19 1996-11-12 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
SE9200199L (sv) * 1992-01-24 1993-07-25 Rune Soeremark Farmaceutisk komposition och dess anvaendning
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
IT1255488B (it) * 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
DE19503423A1 (de) * 1995-02-03 1996-08-08 Beiersdorf Ag Antiadhäsive Wirkstoffe
EP0881905A1 (de) * 1996-02-14 1998-12-09 The Procter & Gamble Company Zusammensetzungen für urogenitale und intestinale störungen mit einer planzlichen substanz aus der familie der ericaceae und einem milchsäurebakterien-wachstumsfaktor
US6165997A (en) * 1997-11-20 2000-12-26 Statens Serum Institut Phospholipids having antimicrobial activity with or without the presence of antimicrobials

Also Published As

Publication number Publication date
DE69831878D1 (de) 2006-02-23
EP1072269A4 (de) 2003-08-27
EP1072268A4 (de) 2003-09-03
DE69831609T2 (de) 2006-02-02
ATE304362T1 (de) 2005-09-15
CN1120001C (zh) 2003-09-03
EP1072269B1 (de) 2005-10-12
AU1223199A (en) 1999-06-15
EP1072268B1 (de) 2005-09-14
CN1120000C (zh) 2003-09-03
US6440949B1 (en) 2002-08-27
EP1072269A1 (de) 2001-01-31
EP1072268A1 (de) 2001-01-31
CN1271290A (zh) 2000-10-25
AU1223099A (en) 1999-06-15
US6632796B1 (en) 2003-10-14
DE69831609D1 (de) 2005-10-20
WO1999026635A1 (fr) 1999-06-03
WO1999026636A1 (fr) 1999-06-03
CN1271291A (zh) 2000-10-25

Similar Documents

Publication Publication Date Title
ATE306274T1 (de) Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis
BR9808520A (pt) Medicamento vaginal de lactobacilos
WO2001042457A3 (en) Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s prnas and their uses
EP0380230A3 (de) Immunogenische Zusammensetzungen gegen Gastrin-Peptide
ATE277638T1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
MY113059A (en) Controlled-release dosage forms of azithromycin
IS7770A (is) Hlutleysandi mótefni gegn GDF-8 og notkun theirra
ATE383893T1 (de) Verwendung von oligosacchariden zur stimulierung der produktion von beta-endorphin
DE69322766D1 (de) Formulierung und verwendung von mikroorganismen zur behandlung von vieh
WO2000078341A8 (en) A method for the prophylaxis and/or treatment of medical disorders
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
DE3778852D1 (de) Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4.
WO2000058475A3 (en) Streptococcus pneumoniae antigens
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
IE831920L (en) 2,4-diamino-5-piperazinyl pyrimidines
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
WO2000030660A3 (de) Hyperforin als zytostatikum sowie hyperforin-salbe oder -creme als applikationsform
WO2001057042A3 (de) 4-pyridyl- und 2,4-pyrimidinyl-substituierte pyrrolderivate und ihre anwendung in der pharmazie
WO2004056768A3 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU9391601A (en) Ferment activator based of lactic acid bacteria and method for preparing a dairyproduct using same
WO2000078328A3 (de) VERWENDUNG VON WACHSTUMSHORMON (hGH) ZUR THERAPIE SEXUELLER FUNKTIONSSTÖRUNGEN
RU95105715A (ru) Способ лечения бактериального вагиноза
EP0321094A3 (de) Behandlung von Faktor-VIII-Inhibitoren
沈钦彦 Clinical Observation on Treatment of 89 Cases of Urine Retention with Acupuncture
Fadeev et al. Specific microbiological features of surgical infection of soft tissues

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties